Company Overview and News

 
Kingston Resources raises $4.3 million to advance gold project in Papua New Guinea

2018-02-06 proactiveinvestors.com.au
Kingston Resources Ltd (ASX:KSN) will use $4.3 million raised in an oversubscribed placement to advance exploration at the 2.8 million ounce Misima Gold Project in Papua New Guinea.
Upvote Downvote

 
Kingston Resources intersects lithium at Bynoe project

2017-07-19 proactiveinvestors.com.au
Kingston Resources (ASX:KSN) has intersected promising lithium mineralisation from the first phase of reverse circulation drilling at the Bynoe project in the Northern Territory.
Upvote Downvote

 
Final Results

2017-06-02 londonstockexchange
Ariana Resources plc ("Ariana" or "the Company"), the exploration and development company operating in Turkey, announces its final audited results for the year ended 31 December 2016.   
Upvote Downvote

 
Kingston Resources samples high-grade lithium at Spotted Wonder

2017-03-24 proactiveinvestors.com.au
Kingston Resources (ASX:KSN) has received a high-grade rock chip assay of 9.63% lithium from outcropping pegmatites within its Spotted Wonder Project in the Northern Territory.
Upvote Downvote

 
Cohiba Minerals granted key lithium license near Mt Cattlin mine

2017-02-05 proactiveinvestors.com.au
Cohiba Minerals (ASX:CHK) has been granted the exploration licence for its Mt Cattlin Project by the Department of Mines in Western Australia.
Upvote Downvote

 
Kingston Resources Ltd to acquire advanced gold exploration project

2016-11-29 proactiveinvestors.com.au
Livingstone is an advanced exploration project with an existing JORC2004 resource of 49,900 ounces gold and a number of high-grade drilling intersections indicating potential for additional discoveries. The option provides Kingston with a 12-month period to explore the project and can be exercised at any time over this period. The consideration for the option includes: - 5.5 million restricted Kingston shares and 5 million Kingston options; - Twelve-month exploration commitment of $200,000; and - Upon exercising the option, $300,000 in Kingston shares.
Upvote Downvote

 
Ariana Resources plc : Half-yearly report

2016-09-30 londonstockexchange
Ariana Resources plc ("Ariana" or "the Company"), the gold exploration and development company focused on Turkey, is pleased to announce its unaudited interim results for the six months ended 30 June 2016.
Upvote Downvote

 
Kingston Resources Ltd eyes lithium in Northern Territory’s largest pegmatite field

2016-08-31 proactiveinvestors.com.au
Kingston Resources Ltd (ASX:KSN) has been granted two tenements within the Bynoe Pegmatite Field, one of the largest and economically important pegmatite fields in the Northern Territory. The tenements are located at the northern end of the Bynoe Pegmatite Field, within a historic tin-tantalum field that has been identified as a new lithium exploration region. This area will be an immediate target for near term exploration, including rock chip sampling and soil sampling with an aim to identify drilling targets.
Upvote Downvote

 
Kingston Resources Ltd identifies sizeable lithium target at Mt Cattlin

2016-08-23 proactiveinvestors.com.au
Kingston Resources Ltd (ASX:KSN) has identified two parallel zones measuring up to 650 metres of anomalous lithium at the Deep Purple South prospect within the Mt Cattlin project in Western Australia. Recent work, including a 900-point soil sampling program as well as ongoing mapping and rock chip sampling, has confirmed the potential of the Deep Purple South target. Previous rock chip assays have graded up to 3.
Upvote Downvote

 
WPG Resources Ltd secures cash to buy gold mine

2016-08-19 proactiveinvestors.com.au
WPG Resources Ltd (ASX:WPG) has raised $6.3 million from an underwritten rights issue taking the total raised to $13.7 million including the recent placement. Funds are being used to acquire the remaining 50% of the operating Challenger gold mine in South Australia. The purchase price is $9 million plus the issue of 25 million options to joint venture partner Diversified Minerals Pty Ltd, related to PYBAR Mining Services, the mine’s contractor.
Upvote Downvote

 
WPG Resources Ltd's shares on the move

2016-08-18 proactiveinvestors.com.au
WPG Resources Ltd (ASX:WPG) has responded to an ASX Price Query after the company's stock jumped 31% to $0.11 intra-day today, compared to the closing price two session prior. WPG said that it is not aware of any information which could explain the trading. The company is moving towards 100% ownership (from 50%) of the operating Challenger gold mine in South Australia. The Challenger gold mine resumed production and site operations during May 2016 after being acquired in March 2016 from Kingsgate Consolidated (ASX:KSN).
Upvote Downvote

 
Cohiba Minerals Ltd joins lithium race with five new acquisitions

2016-08-18 proactiveinvestors.com.au
Cohiba Minerals Ltd (ASX:CHK) can move ahead with the acquisitions of five promising lithium projects in Western Australia after obtaining a waiver from the ASX to issue shares to the vendor. The grant of the waiver will enable the finalisation of a notice of meeting seeking approval required for the acquisition. The vendor, Charge Lithium Pty Ltd, controls 100% of the projects within and around the Mt Cattlin, Pilgangoora and Greenbushes lithium provinces.
Upvote Downvote

 
WPG Resources Ltd's entitlement offer closes today

2016-08-16 proactiveinvestors.com.au
WPG Resources Ltd (ASX:WPG) is set to wrap up its 1:6 entitlement offer today, which closes at 5pm (Sydney time). The offer is fully underwritten, and is part of a broader $13.5 million capital raising to fund the acquisition of the remaining 50% of the operating Challenger gold mine in South Australia. The purchase price is $9 million plus the issue of 25 million options to joint venture partner Diversified Minerals Pty Ltd, related to PYBAR Mining Services, the mine’s contractor.
Upvote Downvote

 
WPG Resources Ltd raising funds to buy full control of Challenger gold mine

2016-07-27 proactiveinvestors.com.au
WPG Resources Ltd (ASX:WPG) will kick off a $13.5 million capital raising to fund the acquisition of the remaining 50% of the operating Challenger gold mine in South Australia. The purchase price is $9 million plus the issue of 25 million options to joint venture partner Diversified Minerals Pty Ltd, related to PYBAR Mining Services, the mine’s contractor. The $13.5 million capital raising will be comprised of a $7.
Upvote Downvote

 
WPG Resources Ltd achieving design rates at Challenger gold mine

2016-07-25 proactiveinvestors.com.au
WPG Resources Ltd (ASX:WPG) is making strong headway towards its previously provided aspirational production target of 50,000 ounces of gold per annum from the Challenger gold mine in South Australia. Over 1,000 ounces of gold has been mined for each of the first three weeks of July. A record of almost 250 ounces was mined and hauled to surface during a single day last week. Gold production continued to increase throughout July and planned output rates have now been achieved.
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

2018-04-25 - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...